Latest News

Comparing NexPoint Residential Trust (NYSE:NXRT) & Brookfield Property Reit (NYSE:BPR)

Comparing NexPoint Residential Trust (NYSE:NXRT) & Brookfield Property Reit (NYSE:BPR)

NexPoint Residential Trust (NYSE:NXRT) and Brookfield Property Reit (NASDAQ:BPR) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, risk and valuation. Analyst Recommendations This is a summary of recent ratings and target prices for NexPoint Residential Trust and Brookfield […]

by November 18, 2019
Tower Research Capital LLC TRC Sells 31,987 Shares of Vanguard Russell 2000 (NASDAQ:VTWO)

Tower Research Capital LLC TRC Sells 31,987 Shares of Vanguard Russell 2000 (NASDAQ:VTWO)

Tower Research Capital LLC TRC decreased its stake in shares of Vanguard Russell 2000 (NASDAQ:VTWO) by 54.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,225 shares of the company’s stock after selling 31,987 shares during the period. Tower Research Capital LLC TRC owned approximately 0.22% […]

by November 18, 2019
Tower Research Capital LLC TRC Buys New Position in iShares MSCI Emerging Markets ETF (NYSEARCA:EEM)

Tower Research Capital LLC TRC Buys New Position in iShares MSCI Emerging Markets ETF (NYSEARCA:EEM)

Tower Research Capital LLC TRC purchased a new stake in iShares MSCI Emerging Markets ETF (NYSEARCA:EEM) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 66,560 shares of the exchange traded fund’s stock, valued at approximately $2,720,000. Several other hedge funds and other institutional investors also recently […]

by November 18, 2019
ANI Pharmaceuticals (NASDAQ:ANIP) Price Target Lowered to $75.00 at Raymond James

ANI Pharmaceuticals (NASDAQ:ANIP) Price Target Lowered to $75.00 at Raymond James

ANI Pharmaceuticals (NASDAQ:ANIP) had its price objective cut by investment analysts at Raymond James from $82.00 to $75.00 in a report issued on Thursday, November 7th, Stock Target Advisor reports. The firm currently has an “outperform” rating on the specialty pharmaceutical company’s stock. Raymond James’ price target would suggest a potential upside of 33.74% from the company’s current price. ANIP […]

by November 18, 2019
$58.83 Million in Sales Expected for Materialise NV (NASDAQ:MTLS) This Quarter

$58.83 Million in Sales Expected for Materialise NV (NASDAQ:MTLS) This Quarter

Wall Street analysts expect that Materialise NV (NASDAQ:MTLS) will announce sales of $58.83 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Materialise’s earnings. The lowest sales estimate is $57.72 million and the highest is $59.94 million. Materialise posted sales of $56.12 million in the same quarter last year, which suggests a […]

by November 18, 2019